Zhong-Bao Ruan1, Ge-Cai Chen2, Yin Ren2, Li Zhu2. 1. Department of Cardiology, Jiangsu Taizhou People's Hospital, No.210, Yinchun Road, Taizhou, Jiangsu, 225300, China. tzcardiac@163.com. 2. Department of Cardiology, Jiangsu Taizhou People's Hospital, No.210, Yinchun Road, Taizhou, Jiangsu, 225300, China.
Abstract
BACKGROUND: Since only 60-70% of select patients with chronic heart failure (CHF) are responders in cardiac resynchronization therapy (CRT), this study aimed to investigate whether serum cystatin C (Cys C) can be used to evaluate the effectiveness of CRT in patients with CHF. METHODS: Seventy-six patients implanted with CRT were retrospectively enrolled. The concentration of serum Cys C was detected and echocardiography was performed before and after 15 days, 1 month, and 6 months of CRT. RESULTS: There were 52 patients (68.4%) who responded to CRT during the follow-up. In the responding group, compared with the pre-CRT, the cardiac function, QRS interval, left ventricular end-diastolic volume (LVEDV), left ventricular end-systolic volume (LVESV), and left ventricular ejection fraction (LVEF) were significantly improved at 6 months after implantation (P < 0.05), but the level of serum Cys C decreased significantly from 1 month after CRT. There was no change of all the parameters in the non-responding group during the follow-up. In the responding group, the ΔCys C% is significantly related to the ΔLVEDV%, ΔLVESV%, and ΔLVEF%. Multivariate linear analysis shows that the ΔCys C% is significantly related to the ΔLVEDV%. The level of serum Cys C before CRT implantation could predict the response to CRT (AUC = 0.78, P < 0.05). Univariate analysis and multivariate analysis demonstrated that the level of Cys C remained independent predictor for CRT (P = 0.028, 95% CI 0.919-1.348). CONCLUSIONS: The level of serum Cys C before CRT implantation is valuable in predicting the response to CRT.
BACKGROUND: Since only 60-70% of select patients with chronic heart failure (CHF) are responders in cardiac resynchronization therapy (CRT), this study aimed to investigate whether serum cystatin C (Cys C) can be used to evaluate the effectiveness of CRT in patients with CHF. METHODS: Seventy-six patients implanted with CRT were retrospectively enrolled. The concentration of serum Cys C was detected and echocardiography was performed before and after 15 days, 1 month, and 6 months of CRT. RESULTS: There were 52 patients (68.4%) who responded to CRT during the follow-up. In the responding group, compared with the pre-CRT, the cardiac function, QRS interval, left ventricular end-diastolic volume (LVEDV), left ventricular end-systolic volume (LVESV), and left ventricular ejection fraction (LVEF) were significantly improved at 6 months after implantation (P < 0.05), but the level of serum Cys C decreased significantly from 1 month after CRT. There was no change of all the parameters in the non-responding group during the follow-up. In the responding group, the ΔCys C% is significantly related to the ΔLVEDV%, ΔLVESV%, and ΔLVEF%. Multivariate linear analysis shows that the ΔCys C% is significantly related to the ΔLVEDV%. The level of serum Cys C before CRT implantation could predict the response to CRT (AUC = 0.78, P < 0.05). Univariate analysis and multivariate analysis demonstrated that the level of Cys C remained independent predictor for CRT (P = 0.028, 95% CI 0.919-1.348). CONCLUSIONS: The level of serum Cys C before CRT implantation is valuable in predicting the response to CRT.
Entities:
Keywords:
Cardiac resynchronization therapy; Chronic heart failure; Cystatin C
Authors: Martin St John Sutton; Cecilia Linde; Michael R Gold; William T Abraham; Stefano Ghio; Jeffrey Cerkvenik; Jean-Claude Daubert Journal: JACC Heart Fail Date: 2017-03 Impact factor: 12.035
Authors: Marcus Ståhlberg; Frieder Braunschweig; Fredrik Gadler; Lars Mortensen; Lars H Lund; Cecilia Linde Journal: Scand Cardiovasc J Date: 2016-08-30 Impact factor: 1.589
Authors: Adelina Doltra; Bart Bijnens; José M Tolosana; Roger Borràs; Malek Khatib; Diego Penela; Teresa Maria De Caralt; María Ángeles Castel; Antonio Berruezo; Josep Brugada; Lluís Mont; Marta Sitges Journal: JACC Cardiovasc Imaging Date: 2014-09-17